New nutritional challenges emerge for HIV care providers

September 22, 2005

Nutritional therapy for HIV-infected patients is shifting focus. Drug treatments designed to combat the HIV virus have improved, decreasing some nutritional problems, while bringing others to light. As researchers from the Nutrition/Infection Unit in the Department of Public Health and Family Medicine at Tufts University School of Medicine describe in an editorial review and other research reports, new nutritional challenges in HIV/AIDS care have emerged.

The changes, according to Alice Tang, MS, PhD, assistant professor at Tufts University School of Medicine, and her colleagues, have resulted from the introduction of an advanced class of drugs called highly active antiretroviral therapy (HAART) over a decade ago.

In the past, the nutritional component of HIV/AIDS care was directed toward two major goals: supplying the vital nutrients that were often lost through poorly-functioning digestive tracts and minimizing weight loss. "The newer medications keep patients healthier overall, so we are not dealing with quite as much severe weight loss," says Tang. "Now we are able to concentrate more on determining the vitamin and mineral ('micronutrient') requirements of these patients and investigating potential therapeutic uses of supplements."

This is particularly important in the age of HAART, according to Tang, who has researched the role of antioxidants, like vitamin E, in HIV extensively. As it turns out, HAART medications, while controlling disease progression for many patients, may also increase oxidative stress. "Oxidative stress" refers to the state of imbalance that exists when chemically unstable by-products of metabolism exceed the body's capacity to quench them, either with its own natural antioxidants or with those obtained from the diet. The potential result of this imbalance is damage to cells and tissues. "Research efforts must focus on determining if this is, indeed, true. If so, what is the mechanism? Will dietary or supplemental antioxidants help?" asks Tang.

Another area of active research underway at Tufts and elsewhere relates to what Tang calls, "one of the most vexing issues facing HIV-positive individuals." In fat redistribution or lipodystrophy syndrome, "body fat changes may include fat loss under the skin (on the trunk, extremities, buttocks or face) and/or fat gain (in the abdomen, back of the neck or in the breasts)" explains Denise Jacobson, PhD, MPH, assistant professor at Tufts School of Medicine. Patients with this condition may also have abnormal metabolism of fat and/or sugar. Jacobson says, "we are still learning about these changes, some of which may be related to HAART."

Over the years, the Nutrition/Infection Unit, led by Sherwood Gorbach, MD, professor of medicine, and Christine Wanke, MD, professor of medicine, has been active in nutrition and HIV research. In the current paper, which is just one of Tang's several reviews analyzing the research in the field, she summarizes the findings of studies looking at the roles of vitamins B12, A, and E in HIV transmission and disease progression. Results are mixed and inconclusive, but Tang says that these findings help to guide researchers in future endeavors. She says, "it is clear that micronutrients play a critical role in the maintenance of immune function and overall metabolism. We need to concentrate on defining the areas in which they may help to maximize the health status of HIV-infected patients."
-end-
Tang AM, Lanzillotti J, Hendricks K, Gerrior J, Ghosh M, Woods M, Wanke C. AIDS. 2005, 19:847-861. "Micronutrients: current issues for HIV care providers."

Jacobson DL, Knox T, Spiegelman D, Skinner S, Gorbach S, Wanke C. Clinical Infectious Diseases. 2005; 40: 1837-1845. "Prevalence of, evolution of, and risk factors for fat atrophy and fat deposition in a cohort of HIV-infected men and women."

Other research from the Nutrition/Infection Unit in the Department of Public Health and Family Medicine at Tufts University School of Medicine in Boston

Burgess E, Wanke C. Current Opinions in Infectious Diseases. 2005; 18(1):17-24. "Use of recombinant human growth hormone in HIV-associated lipodystrophy."

Dong KR, Hendricks KM. Nutrition in Clinical Care. 2005; 8(1):31-36. "The role of nutrition in fat deposition and fat atrophy in patients with HIV."

Gerrior JL, Neff LM. Nutrition in Clinical Care. 2005; 8(1): 6-15. "Nutrition assessment in HIV infection."

Mwamburi DM, Wilson IB, Jacobson DL, Spiegelman D, Gorbach SL, Knox TA, Wanke CA. Clinical Infectious Diseases. 2005; 40(1): 167-173. "Understanding the role of HIV load in determining weight change in the era of highly active antiretroviral therapy."

Woods MN. Nutrition in Clinical Care. 2005; 8(1): 34-30. "Role of n-3 fatty acids in prevention of disease complications in patients with HIV."

Tufts University

Related HIV Articles from Brightsurf:

BEAT-HIV Delaney collaboratory issues recommendations measuring persistent HIV reservoirs
Spearheaded by Wistar scientists, top worldwide HIV researchers from the BEAT-HIV Martin Delaney Collaboratory to Cure HIV-1 Infection by Combination Immunotherapy (BEAT-HIV Collaboratory) compiled the first comprehensive set of recommendations on how to best measure the size of persistent HIV reservoirs during cure-directed clinical studies.

The Lancet HIV: Study suggests a second patient has been cured of HIV
A study of the second HIV patient to undergo successful stem cell transplantation from donors with a HIV-resistant gene, finds that there was no active viral infection in the patient's blood 30 months after they stopped anti-retroviral therapy, according to a case report published in The Lancet HIV journal and presented at CROI (Conference on Retroviruses and Opportunistic Infections).

Children with HIV score below HIV-negative peers in cognitive, motor function tests
Children who acquired HIV in utero or during birth or breastfeeding did not perform as well as their peers who do not have HIV on tests measuring cognitive ability, motor function and attention, according to a report published online today in Clinical Infectious Diseases.

Efforts to end the HIV epidemic must not ignore people already living with HIV
Efforts to prevent new HIV transmissions in the US must be accompanied by addressing HIV-associated comorbidities to improve the health of people already living with HIV, NIH experts assert in the third of a series of JAMA commentaries.

The Lancet HIV: Severe anti-LGBT legislations associated with lower testing and awareness of HIV in African countries
This first systematic review to investigate HIV testing, treatment and viral suppression in men who have sex with men in Africa finds that among the most recent studies (conducted after 2011) only half of men have been tested for HIV in the past 12 months.

The Lancet HIV: Tenfold increase in number of adolescents on HIV treatment in South Africa since 2010, but many still untreated
A new study of more than 700,000 one to 19-year olds being treated for HIV infection suggests a ten-fold increase in the number of adolescents aged 15 to 19 receiving HIV treatment in South Africa, according to results published in The Lancet HIV journal.

Starting HIV treatment in ERs may be key to ending HIV spread worldwide
In a follow-up study conducted in South Africa, Johns Hopkins Medicine researchers say they have evidence that hospital emergency departments (EDs) worldwide may be key strategic settings for curbing the spread of HIV infections in hard-to-reach populations if the EDs jump-start treatment and case management as well as diagnosis of the disease.

NIH HIV experts prioritize research to achieve sustained ART-free HIV remission
Achieving sustained remission of HIV without life-long antiretroviral therapy (ART) is a top HIV research priority, according to a new commentary in JAMA by experts at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

The Lancet HIV: PrEP implementation is associated with a rapid decline in new HIV infections
Study from Australia is the first to evaluate a population-level roll-out of pre-exposure prophylaxis (PrEP) in men who have sex with men.

Researchers date 'hibernating' HIV strains, advancing BC's leadership in HIV cure research
Researchers have developed a novel way for dating 'hibernating' HIV strains, in an advancement for HIV cure research.

Read More: HIV News and HIV Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.